Ken Fisher's position in United Therapeutics is currently worth $4.92 Million. That's 0.00% of their equity portfolio (482nd largest holding). The first United Therapeutics trade was made in Q1 2015. Since then Ken Fisher bought shares eleven more times and sold shares on five occasions. The investor's estimated purchase price is $5.29 Million, resulting in a loss of 6.9%.